By studying those consanguineous families with autism, epilepsy, and intellectual disability, researchers have found mutations in the inactivating gene BCKDK. Patients with homozygous BCKDK mutations show decreasing messenger RNA and protein of BCKDK and plasma BCAAs. Here, BCKDK is linked to autism.